KRAS and colorectal carcinoma: Knocking down SLC25A22 leads to a reduction in Asp biosynthesis and cell proliferation, and an increase in apoptosis, which in turn reduce tumor formation and metastasis in KRAS‐mutant CRC cells in mice.148